Health Condition 1: H60-H95- Diseases of the ear and mastoid process
Conditions
Interventions
Intervention1: Amplification with Neurofeedback training: The treatment group will receive Neurofeedback training for eight weeks with two to four sessions per week. Each neurofeedback back session in
Sponsors
Department ofi Science and Technology
Eligibility
Inclusion criteria
Inclusion criteria: Group 1: Phase 1: Pure tone audiometric threshold should be below 30 dBHL at mid-frequencies and high frequencies. It should be sensorineural hearing loss without any air bone gap. Thresholds will be obtained using modified Hugson and Westlake method Should pass cognitive screening done using MOCA. Systemic problems like diabetes and blood pressure should be under control. Participants should have normal middle ear functioning which will be confirmed using Interacoustics AT235H middle ear analyzer. (Ascending and descending Method) (1959). Participants willing to commute for each session. Group 2: Participant should have SNHL (Sensorineural Hearing loss), PTA less than equal to 60dBHL Participants should have normal middle ear functioning which will be confirmed using middle ear analyzer. No cognitive impairment screened using MOCA. Systemic problems like diabetes and blood pressure should be under control. Should be willing to procure multichannel hearing aid. Participants willing to commute for each session. Phase 2: Participant should have SNHL (Sensorineural Hearing loss), PTA less than equal to 60dBHL Participants should have normal middle ear functioning which will be confirmed using middle ear analyzer. No cognitive impairment screened using MOCA. Systemic problems like diabetes and blood pressure should be under control. Should be willing to procure multichannel hearing aid. Average or poor performers based on reg flag matrix (ANL score 8 to 12 and SNR loss 3 to 17)
Exclusion criteria
Exclusion criteria: Past or present history of middle ear surgery will be excluded from the study. Any other neurological conditions which will be screened using Quick Neurological Screening Test (Margaret Mutti 1974) – available at Dept of Speech and Hearing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study systematically explains the effect of ARHL on listening and its relationship with cognition and cortical modulation qEEG, sLORETA. This study proposes using neurofeedback-based listening training and tests its efficacy using a group of poor performers. If found effective, it could be clinically viable and an evidence-based management approach that can benefit a large population. To check whether poor cognition is associated with a higher degree of hearing loss and what the EEG and ERP changes underlying it are. Whether the rehabilitation with a hearing aid alone can reverse the hearing loss-induced changes. Timepoint: 0 weeks 8 weeks 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| In poor performers with hearing aids, can neurofeedback-based speech in noise retraining improve the cognitive changes associated with the listening effort.Timepoint: 0 weeks 8 weeks 6 months | — |
Countries
India
Contacts
Public ContactHari Prakash P
Manipal College of Health Professions
Outcome results
None listed